Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis

BACKGROUND: Elderly patients tend to be underrepresented in renal cell carcinoma (RCC) clinical trials. The Sorafenib RCC Integrated Database includes data from six clinical trials and two expanded-access studies evaluating sorafenib monotherapy in >4600 patients with RCC. Using this database, so...

Descripción completa

Detalles Bibliográficos
Autores principales: Procopio, G, Bellmunt, J, Dutcher, J, Bracarda, S, Knox, J, Brueckner, A, Molnar, I, Escudier, B, Hutson, T E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566810/
https://www.ncbi.nlm.nih.gov/pubmed/23322192
http://dx.doi.org/10.1038/bjc.2012.543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566810/
https://www.ncbi.nlm.nih.gov/pubmed/23322192
http://dx.doi.org/10.1038/bjc.2012.543

Ejemplares similares